Credit Suisse’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-55,652
| Closed | -$1.05M | – | 4462 |
|
|
2019
Q3 | $1.05M | Sell |
55,652
-102,616
| -65% | -$1.17M | ﹤0.01% | 2976 |
|
|
2019
Q2 | $1.86M | Buy |
158,268
+114,851
| +265% | +$1.39M | ﹤0.01% | 2507 |
|
|
2019
Q1 | $593K | Sell |
43,417
-8,390
| -16% | -$109K | ﹤0.01% | 3239 |
|
|
2018
Q4 | $531K | Sell |
51,807
-271,163
| -84% | -$3.47M | ﹤0.01% | 3216 |
|
|
2018
Q3 | $5.38M | Buy |
322,970
+183,855
| +132% | +$3.32M | ﹤0.01% | 1650 |
|
|
2018
Q2 | $2.2M | Sell |
139,115
-71,262
| -34% | -$1.08M | ﹤0.01% | 2367 |
|
|
2018
Q1 | $2.67M | Buy |
210,377
+154,169
| +274% | +$2.23M | ﹤0.01% | 2190 |
|
|
2017
Q4 | $643K | Sell |
56,208
-33,303
| -37% | -$372K | ﹤0.01% | 3293 |
|
|
2017
Q3 | $1.1M | Sell |
89,511
-43,013
| -32% | -$448K | ﹤0.01% | 3029 |
|
|
2017
Q2 | $1.52M | Sell |
132,524
-111,283
| -46% | -$2.06M | ﹤0.01% | 2412 |
|
|
2017
Q1 | $5.07M | Buy |
243,807
+40,260
| +20% | +$891K | ﹤0.01% | 1646 |
|
|
2016
Q4 | $4.23M | Buy |
203,547
+708
| +0.3% | +$18.4K | ﹤0.01% | 1775 |
|
|
2016
Q3 | $6.65M | Buy |
202,839
+15,927
| +9% | +$485K | 0.01% | 1446 |
|
|
2016
Q2 | $4.67M | Buy |
186,912
+279
| +0.1% | +$7.55K | 0.01% | 1681 |
|
|
2016
Q1 | $4.57M | Buy |
186,633
+72,636
| +64% | +$1.68M | 0.01% | 1606 |
|
|
2015
Q4 | $3.77M | Buy |
113,997
+20,332
| +22% | +$688K | ﹤0.01% | 1809 |
|
|
2015
Q3 | $3.07M | Buy |
93,665
+36,411
| +64% | +$1.55M | ﹤0.01% | 1949 |
|
|
2015
Q2 | $3.03M | Buy |
57,254
+20,794
| +57% | +$756K | ﹤0.01% | 2206 |
|
|
2015
Q1 | $1.05M | Buy |
36,460
+21,396
| +142% | +$587K | ﹤0.01% | 2927 |
|
|
2014
Q4 | $439K | Sell |
15,064
-2,300
| -13% | -$41.3K | ﹤0.01% | 3801 |
|
|
2014
Q3 | $220K | Buy |
+17,364
| New | +$262K | ﹤0.01% | 4090 |
|
Credit Suisse's ALDR Position: Q4 2019 in Review
Credit Suisse sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 55,652 shares — an estimated $1.05M sold.
Credit Suisse first reported a position in ALDR in Q3 2014 and held it in 21 quarters. The position peaked at $6.65M in Q3 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Credit Suisse reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Credit Suisse sold 55,652 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.05M.
- Credit Suisse first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 21 quarters.
- Credit Suisse's Alder Biopharmaceuticals position peaked at $6.65M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.